Typhoid Fever Vaccines Market Share and Future Growth to 2026 | SWOT Analysis by Players GlaxoSmithKline Plc., Sanofi SA, Bharat Biotech, Bio-Med Pvt. Ltd., PT Bio Farma, PaxVax, Inc. Shanghai Institute of Biological Products Co., Ltd., Prokarium

Typhoid fever, also simply called as typhoid is a bacterial infection caused by Salmonella typhi, also known as Salmonella enterica serotype Typhi. The typhoid fever is usually caused due to ingestion of contaminated food or water. Typhoid vaccines prevents typhoid fever and provide protection against it. World Health Organization (WHO) has recommended three typhoid vaccines for use, which include live attenuated vaccine, capsular polysaccharide vaccines, and conjugate vaccine

Increasing government initiatives promoting and advancing development of innovative products

Organizations such as World Health Organization (WHO), Gavi, Bill & Melinda Gates Foundation, and others are highly active in creating awareness regarding typhoid and driving immunization efforts against such diseases. In October 2017, WHO recommended introduction of typhoid vaccine for children over six months in endemic countries. It also recommended catch-up vaccination whenever possible, prioritizing children and adolescents up to 15 years of age.

Click the link to Get a Sample Copy of the Typhoid Fever Vaccines Research Report: https://www.coherentmarketinsights.com/insight/request-sample/2552

World Health Organization (WHO), pre-qualified a typhoid conjugate vaccine (TCV) Typbar TCV, manufactured by Bharat Biotech in December 2017. WHO pre-qualification enables the procurement and supply of this vaccine to UNICEF, the Pan-American Health Organization (PAHO), and GAVI (a vaccine alliance) supported countries. Such frequent initiatives taken by various organizations is expected to support the market growth over the forecast period.

Asia Pacific is expected to hold dominant position in the market owing to high prevalence of typhoid fever in the region

Asia Pacific is expected to be most lucrative region for typhoid fever vaccines market growth, owing to countries such as India, Pakistan, and Bangladesh are endemic to typhoid wherein the demand for typhoid vaccine is every high. For instance, according to the data published by Med India around 18, 45,997 cases of typhoid were found in India in 2015. Furthermore, presence of key typhoid vaccine manufacturers in region and development and launch of novel vaccines by them is also expected to drastically drive market growth over the forecast period.

Reimbursement Scenario -

Vaccination/Immunizations are generally not covered under medicare, unless they are directly related to the treatment of an injury or direct exposure to a disease or condition, such as anti-rabies treatment or tetanus antitoxin or booster vaccine. In absence of such condition where an injury or direct exposure has happened, vaccination (preventive immunization) against diseases such as smallpox, typhoid and polio, are not covered.

In cases where a vaccination or inoculation is excluded from coverage, the entire charge will be denied (such as office visits, which are primarily for the purpose of administering a non-covered injection).

Market Opportunity -

Currently, there is only one typhoid conjugate vaccine that has been prequalified by WHO (Typbar TCV) to treat young children below two years of age. Typhoid conjugate vaccine (TCV) is more effective at preventing the disease than other available vaccines. It is long lasting, provides protection for at least five years and possibly longer, as compared to just two years for earlier typhoid vaccines. Childhood vaccination schedules are still devoid of a typhoid vaccine. However, with introduction of Typbar TCV, the scenario is expected to change, as these vaccines would be included in the childhood vaccination schedules giving immunity against typhoid to infants early.

Market Key Players -

Key players operating in the typhoid fever vaccines market include GlaxoSmithKline Plc., Sanofi SA, Bharat Biotech, Bio-Med Pvt. Ltd., PT Bio Farma, PaxVax, Inc. Shanghai Institute of Biological Products Co., Ltd., and Prokarium

Detailed Segmentation:

Global Typhoid Fever Vaccines Market, By Vaccine Type :
Live Attenuated Vaccine
Capsular Polysaccharide Vaccines
Conjugate Vaccine
Others

Global Typhoid Fever Vaccines Market, By Route of Administration:
Oral
Parenteral

Request For Customization of Typhoid Fever Vaccines Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/2552

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.